Autoimmune diabetes is a heterogeneous disease which can arise at any age. Subjects with adult-onset autoimmune diabetes who do not necessitate insulin-therapy for at least 6 months after diagnosis are demarcated as having latent autoimmune diabetes in adults (LADA). This condition is more heterogeneous than young-onset autoimmune diabetes and shares clinical and metabolic characteristics with both type 2 and type 1 diabetes. Patients with LADA are considered by having highly variable β-cell destruction, different degrees of insulin resistance and heterogeneous titre and pattern of islet autoantibody, suggesting different pathophysiological pathways partially explaining the heterogeneous phenotypes of LADA. To date the heterogeneity of LADA does not allow to establish a priori treatment algorithm and no specific guidelines for LADA therapy are available. These subjects are mostly treated as affected by type 2 diabetes, a factor that might lead to the progression to insulin-dependency quickly. A personalised medicine approach is necessary to attain optimal metabolic control and preserve β-cell function to decrease the risk of long-term diabetes complications. Recent data concerning the use of oral antidiabetic agents as dipeptidyl peptidase 4 inhibitors and glucagon-like peptide 1 receptor agonists indicate up-and-coming results in term of protect C-peptide levels and improving glycaemic control. This review summarises current knowledge on LADA, emphasising controversies regarding its pathophysiology and clinical features. Moreover, we discuss data available about novel therapeutic approaches that can be considered for prevention of β-cell loss in LADA.

Citations

Citations to this article as recorded by  

• Drug candidates and potential targets of Curculigo spp. compounds for treating diabetes mellitus based on network pharmacology, molecular docking and molecular dynamics simulation
  Abdul Halim Umar, Diah Ratnadewi, Mohamad Rafi, Yohana Caecilia Sulistyaningsih, Hamim Hamim, Wisnu Ananta Kusuma
  Journal of Biomolecular Structure and Dynamics.2023; 41(17): 8544.     CrossRef
• Development and validation of a clinical score for identifying patients with high risk of latent autoimmune adult diabetes (LADA): The LADA primary care-protocol study
  Pilar Vich-Pérez, Juan Carlos Abánades-Herranz, Gustavo Mora-Navarro, Ángela María Carrasco-Sayalero, Miguel Ángel Salinero-Fort, Ignacio Sevilla-Machuca, Mar Sanz-Pascual, Cristina Álvarez Hernández-Cañizares, Carmen de Burgos-Lunar, Vijayaprakash Suppia
  PLOS ONE.2023; 18(2): e0281657.     CrossRef
• Diagnostic Dilemmas and Current Treatment Approaches in Latent Onset Autoimmune Diabetes in Adults: A Concise Review
  Lakshmi Chandran, Ankul Singh S., Chitra Vellapandian
  Current Diabetes Reviews.2023;[Epub]     CrossRef
• Characteristics of adult-onset auto-immune type 1 diabetes
  Faten Hadj Kacem, Ameni Jerbi, Bibi Twaheerah Allymamod, Wafa Bel Abed, Mouna Mnif, Nadia Charfi, Mouna Elleuch, Nabila Rekik, Hatem Masmoudi, Mohamed Abid
  The American Journal of the Medical Sciences.2023; 366(1): 49.     CrossRef
• The role of cholecalciferol deficiency in the development of latent autoimmune diabetes in adults
  I.O. Tsaryk, N.V. Pashkovska
  INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2023; 19(4): 259.     CrossRef
• Newly diagnosed type 1 diabetes mellitus in a human immunodeficiency virus-infected patient with antiretroviral therapy-induced immune reconstitution inflammatory syndrome: a case report
  Min-ChunYeh, Han-Chuan Chuang, Shuen-Fu Weng, Chung-Huei Hsu, Chen-Ling Huang, Yu-Pei Lin, Yan-Yu Lin, Yu-Shan Hsieh
  BMC Infectious Diseases.2023;[Epub]     CrossRef
• A Review on Latent Autoimmune Diabetes in Adults
  Vijay Ravikumar, Ariba Ahmed, Ashish Anjankar
  Cureus.2023;[Epub]     CrossRef
• Exploring Immune Therapies in a Twin Case of Latent Autoimmune Diabetes in Adults and Generalized Granuloma Annulare
  Brian W. Connor, Sarah E.B. Smith, Andrea Kalus
  Clinical Diabetes.2023; 41(4): 583.     CrossRef
• Innate immunity in latent autoimmune diabetes in adults
  Juan Huang, James Alexander Pearson, F. Susan Wong, Li Wen, Zhiguang Zhou
  Diabetes/Metabolism Research and Reviews.2022;[Epub]     CrossRef
• Endocrine Manifestations and New Developments in Mitochondrial Disease
  Yi Shiau Ng, Albert Zishen Lim, Grigorios Panagiotou, Doug M Turnbull, Mark Walker
  Endocrine Reviews.2022; 43(3): 583.     CrossRef
• Two Fifth-Generation Fighter Pilots Discovered with Latent Autoimmune Diabetes
  Joe X. Zhang, Jacob Berry, Nathan M. Kim, Justin J. Gray, Savannah Fotheringham, Tom J. Sauerwein
  Aerospace Medicine and Human Performance.2022; 93(2): 106.     CrossRef
• A Case of Late Diagnosis of Latent Autoimmune Diabetes in Adults
  Joana R Costa, Ana Mestre, Mariana S Miranda, Frederica H Ferreira, Yahia Abuowda
  Cureus.2022;[Epub]     CrossRef
• Class I MHC Polymorphisms Associated with Type 2 Diabetes in the Mexican Population
  Paola Mendoza-Ramírez, Mildred Alejandra López-Olaiz, Adriana Lizeth Morales-Fernández, María Isabel Flores-Echiveste, Antonio de Jesus Casillas-Navarro, Marco Andrés Pérez-Rodríguez, Felipe de Jesús Orozco-Luna, Celso Cortés-Romero, Laura Yareni Zuñiga,
  Genes.2022; 13(5): 772.     CrossRef
• Efficacy and safety of sitagliptin and insulin for latent autoimmune diabetes in adults: A systematic review and meta‐analysis
  Tong Lin, Yinhe Cai, Liting Tang, Youwei Lian, Min Liu, Chaonan Liu
  Journal of Diabetes Investigation.2022; 13(9): 1506.     CrossRef
• Partial Remission of Diabetes in a Young Adult While Testing Positive for Several Islet Cell Autoantibodies: A Case Report, Literature Review, and Patient Perspective
  Samson O Oyibo
  Cureus.2022;[Epub]     CrossRef
• Latent Autoimmune Diabetes in Adults and Metabolic Syndrome—A Mini Review
  Niansi Pan, Shimei Yang, Xiaohong Niu
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Prevalence and factors associated with latent autoimmune diabetes in adults (LADA): a cross-sectional study
  Anselmo M. Manisha, Aminiel R. Shangali, Sayoki G. Mfinanga, Erasto V. Mbugi
  BMC Endocrine Disorders.2022;[Epub]     CrossRef
• Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto’s thyroiditis: a case report
  Maria Xenou, Ioannis Zoupas, Dimitrios Lygnos, Evangelos Fousteris
  Journal of Medical Case Reports.2022;[Epub]     CrossRef
• Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy
  Jingyi Hu, Rong Zhang, Hailan Zou, Lingxiang Xie, Zhiguang Zhou, Yang Xiao
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Adult-onset autoimmune diabetes
  Raffaella Buzzetti, Ernesto Maddaloni, Jason Gaglia, R. David Leslie, F. Susan Wong, Bernhard O. Boehm
  Nature Reviews Disease Primers.2022;[Epub]     CrossRef
• Diagnostic camouflage: A case report on Latent autoimmune diabetics of adulthood
  Sandhya kiran Neupane, Prakash Paudel Jaishi, Divyaa Koirala, Arjun Kandel, Prabhat Kiran Neupane
  Annals of Medicine and Surgery.2022; 82: 104699.     CrossRef
• A Mechanistic Insight on Phytoconstituents Delivering Hypoglycemic Activity: A Comprehensive Overview
  Shraddha Singh Raghav, Bhavna Kumar, Neeraj Kumar Sethiya, Ankur Kaul
  Future Pharmacology.2022; 2(4): 511.     CrossRef
• Diagnostic dilemmas in young onset diabetes mellitus
  Avijit Saha, Parna Roy
  Annals of Medical Science and Research.2022; 1(3): 111.     CrossRef
• Prevalence of diabetes-associated autoantibodies among patients presenting with type 2 diabetes and related metabolic differences
  Fatemeh Moosaie, Neda Meftah, Niloofar Deravi, Kosar Abouhamzeh, Fatemeh Dehghani Firouzabadi, Pegah Khaloo, Mohammad Ali Mansournia, Seyede Marzie Fatemi Abhari, Manouchehr Nakhjavani, Alireza Esteghamati
  Primary Care Diabetes.2021; 15(1): 169.     CrossRef
• The association of human leukocyte antigen class II (HLA II) haplotypes with the risk of Latent autoimmune diabetes of adults (LADA): Evidence based on available data
  Wenjun Chen, Xinlin Chen, Minting Zhang, Zunnan Huang
  Gene.2021; 767: 145177.     CrossRef
• A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes
  Thomas Forst, Pratik Choudhary, Doron Schneider, Bruno Linetzky, Paolo Pozzilli
  Diabetes/Metabolism Research and Reviews.2021;[Epub]     CrossRef
• Bewusstseinsstörung, Tachypnoe und Tachykardie bei einem 71-jährigen Patienten mit Diabetes mellitus Typ 2
  S. Großmann, U. Hoffmann, C. Girlich
  Der Internist.2021; 62(6): 672.     CrossRef
• Good Glycemic Outcomes Following Bariatric Surgery Among Patients With Type 2 Diabetes, Obesity, and Low-Titer GAD Antibodies
  Ruveena Kaur, David Kim, Richard Cutfield, Michael Booth, Lindsay Plank, Rinki Murphy
  Diabetes Care.2021; 44(2): 607.     CrossRef
• Slowly evolving, immune-mediated diabetes in 14-year-old patient: a case report
  M. R. Ragimov, D. D. Omelchuk, L. I. Ibragimova, O. S. Derevyanko, T. V. Nikonova
  Diabetes mellitus.2021; 24(1): 70.     CrossRef
• Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes
  Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Susana Nogueira Diniz, Andrea Fabbri, Marco Infante
  International Immunopharmacology.2021; 95: 107518.     CrossRef
• Current view of diagnosis and treatment of latent autoimmune diabetes in adults
  Jana Urbanová, Ludmila Brunerová, Jana Malinovská, Barbora Pelechová, Ludmila Koberová, Jan Brož
  Vnitřní lékařství.2021; 67(2): 97.     CrossRef
• Alpha‐amylase as molecular target for treatment of diabetes mellitus: A comprehensive review
  Navjot Kaur, Vanktesh Kumar, Surendra Kumar Nayak, Pankaj Wadhwa, Paranjit Kaur, Sanjeev Kumar Sahu
  Chemical Biology & Drug Design.2021; 98(4): 539.     CrossRef
• CLINICAL AND IMMUNOLOGICAL ASPECTS OF VERIFICATION OF LATENT AUTOIMMUNE DIABETES IN ADULTS AT EARLY STAGES OF DISEASE MANIFESTATION
  Tetiana М. Tykhonova, Igor V. Belozоrov, Nadiya Ye. Barabash, Larysa O. Martymianova
  Wiadomości Lekarskie.2021; 74(7): 1707.     CrossRef
• Bacillus Calmette-Guerin 's beneficial impact on glucose metabolism: Evidence for broad based applications
  Gabriella F. Shpilsky, Hiroyuki Takahashi, Anna Aristarkhova, Michele Weil, Nathan Ng, Kacie J. Nelson, Amanda Lee, Hui Zheng, Willem M. Kühtreiber, Denise L. Faustman
  iScience.2021; 24(10): 103150.     CrossRef
• Multicentre analysis of hyperglycaemic hyperosmolar state and diabetic ketoacidosis in type 1 and type 2 diabetes
  S. R. Tittel, K. M. Sondern, M. Weyer, T. Poeplau, B. M. Sauer, M. Schebek, K.-H. Ludwig, F. Hammer, E. Fröhlich-Reiterer, R. W. Holl
  Acta Diabetologica.2020; 57(10): 1245.     CrossRef
• Pancreas Pathology of Latent Autoimmune Diabetes in Adults (LADA) in Patients and in a LADA Rat Model Compared With Type 1 Diabetes
  Anne Jörns, Dirk Wedekind, Joachim Jähne, Sigurd Lenzen
  Diabetes.2020; 69(4): 624.     CrossRef
• Past, present and future of latent autoimmune diabetes in adults
  Bingwen Liu, Yufei Xiang, Zhenqi Liu, Zhiguang Zhou
  Diabetes/Metabolism Research and Reviews.2020;[Epub]     CrossRef
• Adult-onset autoimmune diabetes in 2020: An update
  Ernesto Maddaloni, Chiara Moretti, Carmen Mignogna, Raffaella Buzzetti
  Maturitas.2020; 137: 37.     CrossRef
• Altered peripheral nerve structure and function in latent autoimmune diabetes in adults
  Tushar Issar, Aimy Yan, Natalie C. G. Kwai, Ann M. Poynten, Adeniyi A. Borire, Ria Arnold, Arun V. Krishnan
  Diabetes/Metabolism Research and Reviews.2020;[Epub]     CrossRef
• Low rate of latent autoimmune diabetes in adults (LADA) in patients followed for type 2 diabetes: A single center’s experience in Turkey
  Abbas Ali Tam, Didem Ozdemir, Nagihan Bestepe, Fatma Dilek Dellal, Muhammet Cuneyt Bilginer, Sevgul Faki, Cemile Bicer, Reyhan Ersoy, Bekir Cakir
  Archives of Endocrinology and Metabolism.2020;[Epub]     CrossRef
• Distinguishing between type 1 and type 2 diabetes
  Alexandra E Butler, David Misselbrook
  BMJ.2020; : m2998.     CrossRef
• Exogenous Insulin Injection-Induced Stiff-Person Syndrome in a Patient With Latent Autoimmune Diabetes: A Case Report and Literature Review
  Yi-Yin Lee, Cheng-Wei Lin, I-Wen Chen
  Frontiers in Endocrinology.2020;[Epub]     CrossRef
• Investigating optimal β‐cell‐preserving treatment in latent autoimmune diabetes in adults: Results from a 21‐month randomized trial
  Ingrid K. Hals, Hanne Fiskvik Fleiner, Nina Reimers, Marianne C. Astor, Karin Filipsson, Zuheng Ma, Valdemar Grill, Anneli Björklund
  Diabetes, Obesity and Metabolism.2019; 21(10): 2219.     CrossRef
• Immunological and clinical characteristics of latent autoimmune diabetes in the elderly
  Silvina Yohena, Alberto Penas‐Steinhardt, Clara Muller, Natalia I. Faccinetti, Gloria E. Cerrone, Silvia Lovecchio, Edgardo Ridner, Silvina Valdez, Gustavo Frechtel
  Diabetes/Metabolism Research and Reviews.2019;[Epub]     CrossRef
• Autoimmunity in latent autoimmune diabetes in adults
  Alessandro P. Delitala
  AIMS Medical Science.2019; 6(2): 132.     CrossRef

Citations

Citations to this article as recorded by  

• Atypical Diabetes: What Have We Learned and What Does the Future Hold?
  Stephen I. Stone, Ashok Balasubramanyam, Jennifer E. Posey
  Diabetes Care.2024; 47(5): 770.     CrossRef
• Insulinogenic index and early phase insulin secretion predict increased risk of worsening glucose tolerance and of cystic fibrosis-related diabetes
  Kathryn J. Potter, Valérie Boudreau, Anne Bonhoure, François Tremblay, Annick Lavoie, Maité Carricart, Peter A. Senior, Rémi Rabasa-Lhoret
  Journal of Cystic Fibrosis.2023; 22(1): 50.     CrossRef
• First-phase insulin secretion: can its evaluation direct therapeutic approaches?
  Gianfranco Di Giuseppe, Gea Ciccarelli, Laura Soldovieri, Umberto Capece, Chiara M.A. Cefalo, Simona Moffa, Enrico C. Nista, Michela Brunetti, Francesca Cinti, Antonio Gasbarrini, Alfredo Pontecorvi, Andrea Giaccari, Teresa Mezza
  Trends in Endocrinology & Metabolism.2023; 34(4): 216.     CrossRef
• Insights on C-peptide in diabetes
  Anuj Maheshwari
  IP Journal of Nutrition, Metabolism and Health Science.2023; 6(2): 63.     CrossRef
• Human Milk Oligosaccharides in Maternal Serum Respond to Oral Glucose Load and Are Associated with Insulin Sensitivity
  Marie-Therese Weiser-Fuchs, Elena Maggauer, Mireille N. M. van Poppel, Bence Csapo, Gernot Desoye, Harald C. Köfeler, Andrea Groselj-Strele, Slave Trajanoski, Herbert Fluhr, Barbara Obermayer-Pietsch, Evelyn Jantscher-Krenn
  Nutrients.2023; 15(18): 4042.     CrossRef
• Elevated Peripheral Brain-Derived Neurotrophic Factor Level Associated With Decreasing Insulin Secretion May Forecast Memory Dysfunction in Patients With Long-Term Type 2 Diabetes
  Xi Huang, Zuolin Xie, Chenchen Wang, Shaohua Wang
  Frontiers in Physiology.2022;[Epub]     CrossRef
• Predictors of Glycemic Outcomes at 1 Year Following Pediatric Total Pancreatectomy With Islet Autotransplantation
  Sarah E. Swauger, Lindsey N. Hornung, Deborah A. Elder, Appakalai N. Balamurugan, David S. Vitale, Tom K. Lin, Jaimie D. Nathan, Maisam Abu-El-Haija
  Diabetes Care.2022; 45(2): 295.     CrossRef
• Data-driven subgroups of type 2 diabetes, metabolic response, and renal risk profile after bariatric surgery: a retrospective cohort study
  Violeta Raverdy, Ricardo V Cohen, Robert Caiazzo, Helene Verkindt, Tarissa Beatrice Zanata Petry, Camille Marciniak, Benjamin Legendre, Pierre Bauvin, Estelle Chatelain, Alain Duhamel, Elodie Drumez, Naima Oukhouya-Daoud, Mikael Chetboun, Gregory Baud, Em
  The Lancet Diabetes & Endocrinology.2022; 10(3): 167.     CrossRef
• The Relationship between the Lipid Accumulation Product and Beta-cell Function in Korean Adults with or without Type 2 Diabetes Mellitus: The 2015 Korea National Health and Nutrition Examination Survey
  Hye Eun Cho, Seung Bum Yang, Mi Young Gi, Ju Ae Cha, so Young Park, Hyun Yoon
  Endocrine Research.2022; 47(2): 80.     CrossRef
• Measures of Maternal Metabolic Health as Predictors of Severely Low Milk Production
  Laurie A. Nommsen-Rivers, Erin A. Wagner, Dayna M. Roznowski, Sarah W. Riddle, Laura P. Ward, Amy Thompson
  Breastfeeding Medicine.2022; 17(7): 566.     CrossRef
• Prediabetes: From diagnosis to prognosis
  Teodora Beljić-Živković
  Galenika Medical Journal.2022; 1(1): 57.     CrossRef
• C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective
  Ernesto Maddaloni, Geremia B. Bolli, Brian M. Frier, Randie R. Little, Richard D. Leslie, Paolo Pozzilli, Raffaela Buzzetti
  Diabetes, Obesity and Metabolism.2022; 24(10): 1912.     CrossRef
• Fasting Proinsulin Independently Predicts Incident Type 2 Diabetes in the General Population
  Sara Sokooti, Wendy A. Dam, Tamas Szili-Torok, Jolein Gloerich, Alain J. van Gool, Adrian Post, Martin H. de Borst, Ron T. Gansevoort, Hiddo J. L. Heerspink, Robin P. F. Dullaart, Stephan J. L. Bakker
  Journal of Personalized Medicine.2022; 12(7): 1131.     CrossRef
• C-peptide is a predictor of telomere shortening: A five-year longitudinal study
  Racha Ghoussaini, Hani Tamim, Martine Elbejjani, Maha Makki, Lara Nasreddine, Hussain Ismaeel, Mona P. Nasrallah, Nathalie K. Zgheib
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Association between early-pregnancy serum C-peptide and risk of gestational diabetes mellitus: a nested case–control study among Chinese women
  Xue Yang, Yi Ye, Yi Wang, Ping Wu, Qi Lu, Yan Liu, Jiaying Yuan, Xingyue Song, Shijiao Yan, Xiaorong Qi, Yi-Xin Wang, Ying Wen, Gang Liu, Chuanzhu Lv, Chun-Xia Yang, An Pan, Jianli Zhang, Xiong-Fei Pan
  Nutrition & Metabolism.2022;[Epub]     CrossRef
• Human C-peptide is a ligand of the elastin-receptor-complex and therewith central to human vascular remodelling and disease in metabolic syndrome
  Gert Wensvoort
  Medical Hypotheses.2022; 168: 110964.     CrossRef
• Lactiplantibacillus plantarum DSM20174 Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation
  José I. Riezu-Boj, Miguel Barajas, Tania Pérez-Sánchez, María J. Pajares, Miriam Araña, Fermín I. Milagro, Raquel Urtasun
  Nutrients.2022; 14(24): 5212.     CrossRef
• Depression Augments Plasma APOA4 without Changes of Plasma Lipids and Glucose in Female Adolescents Carrying G Allele of APOA4 rs5104
  Qi Wei Guo, Yan Jun Si, Yi Lin Shen, Xu Chen, Mei Yang, Ding Zhi Fang, Jia Lin
  Journal of Molecular Neuroscience.2021; 71(10): 2060.     CrossRef
• Insulinemic and Inflammatory Dietary Patterns Show Enhanced Predictive Potential for Type 2 Diabetes Risk in Postmenopausal Women
  Qi Jin, Ni Shi, Desmond Aroke, Dong Hoon Lee, Joshua J. Joseph, Macarius Donneyong, Darwin L. Conwell, Phil A. Hart, Xuehong Zhang, Steven K. Clinton, Zobeida Cruz-Monserrate, Theodore M. Brasky, Rebecca Jackson, Lesley F. Tinker, Simin Liu, Lawrence S. P
  Diabetes Care.2021; 44(3): 707.     CrossRef
• Analytical and clinical comparison between two different chemiluminescent enzyme immunoassays for the measurement of C-peptide in serum
  Gian P. CAVIGLIA, Chiara ROSSO, Angelo ARMANDI, Davide G. RIBALDONE, Rinaldo PELLICANO, Elisabetta BUGIANESI
  Minerva Biotechnology and Biomolecular Research.2021;[Epub]     CrossRef
• Pregnancy Serum DLK1 Concentrations Are Associated With Indices of Insulin Resistance and Secretion
  Clive J Petry, Keith A Burling, Peter Barker, Ieuan A Hughes, Ken K Ong, David B Dunger
  The Journal of Clinical Endocrinology & Metabolism.2021; 106(6): e2413.     CrossRef
• May C-peptide index be a new marker to predict proteinuria in anemic patients with type 2 diabetes mellitus?
  Bilal Katipoglu, Mustafa Comoglu, Ihsan Ates, Nisbet Yilmaz, Dilek Berker
  Endocrine Regulations.2020; 54(1): 1.     CrossRef
• Association between insulin resistance and risk of atrial fibrillation in non-diabetics
  Yonggu Lee, Sung Joo Cha, Jung-Hwan Park, Jeong-Hun Shin, Young-Hyo Lim, Hwan-Cheol Park, Jinho Shin, Chun Ki Kim, Jin-Kyu Park
  European Journal of Preventive Cardiology.2020; 27(18): 1934.     CrossRef
• Circulating levels of selected adipokines in women with gestational diabetes and type 2 diabetes
  David Karasek, Ondrej Krystynik, Dominika Goldmannova, Lubica Cibickova, Jan Schovanek
  Journal of Applied Biomedicine.2020; 18(2-3): 54.     CrossRef
• Search for clinical predictors of good glycemic control in patients starting or intensifying oral hypoglycemic pharmacological therapy: A multicenter prospective cohort study
  Qian Ren, Li-Nong Ji, Ju-Ming Lu, Yu-Feng Li, Quan-Min Li, Shan-Shan Lin, Xiao-Feng Lv, Li Wang, Yuan Xu, Xiao-Hui Guo, Qi-Yu Guo, Li Ma, Jin Du, Ying-Li Chen, Cui-Ling Zhao, Qiu-Lan Zhang, Qi-Mei She, Xiu-Min Jiao, Mei-Hua Lu, Xiao-Meng Sun, Ying Gao, Ji
  Journal of Diabetes and its Complications.2020; 34(2): 107464.     CrossRef
• High Plasma Resistin Levels Portend the Insulin Resistance-Associated Susceptibility to Early Cognitive Decline in Patients with Type 2 Diabetes Mellitus
  Chenchen Wang, Xi Huang, Sai Tian, Rong Huang, Dan Guo, Hongyan Lin, Jiaqi Wang, Shaohua Wang
  Journal of Alzheimer's Disease.2020; 75(3): 807.     CrossRef
• Linearization of the Disposition Index equation allows evaluation of secretion-sensitivity coupling slopes
  Kieren J. Mather, Melinda Chen, Tamara S. Hannon
  Journal of Diabetes and its Complications.2020; 34(7): 107589.     CrossRef
• Impact of interval walking training managed through smart mobile devices on albuminuria and leptin/adiponectin ratio in patients with type 2 diabetes
  Jelizaveta Sokolovska, Karina Ostrovska, Leonora Pahirko, Gunita Varblane, Ksenija Krilatiha, Austris Cirulnieks, Inese Folkmane, Valdis Pirags, Janis Valeinis, Aija Klavina, Leo Selavo
  Physiological Reports.2020;[Epub]     CrossRef
• Gender diversity of insulin sensitivity markers among patients of type 2 diabetes mellitus in northern India: A cross-sectional analytical study
  Ravi Kant, Poonam Yadav, Surekha Kishore
  Journal of Family Medicine and Primary Care.2020; 9(7): 3315.     CrossRef
• Associations of Plasma BACE1 Level and BACE1 C786G Gene Polymorphism with Cognitive Functions in Patients with Type 2 Diabetes: A Cross- Sectional Study
  Sai Tian, Rong Huang, Dan Guo, Hongyan Lin, Jiaqi Wang, Ke An, Shaohua Wang
  Current Alzheimer Research.2020; 17(4): 355.     CrossRef
• PPARGC1A Gene Promoter Methylation as a Biomarker of Insulin Secretion and Sensitivity in Response to Glucose Challenges
  José L. Santos, Bernardo J. Krause, Luis Rodrigo Cataldo, Javier Vega, Francisca Salas-Pérez, Paula Mennickent, Raúl Gallegos, Fermín I. Milagro, Pedro Prieto-Hontoria, J. Ignacio Riezu-Boj, Carolina Bravo, Albert Salas-Huetos, Ana Arpón, José E. Galgani,
  Nutrients.2020; 12(9): 2790.     CrossRef
• Plasma C-Peptide and Risk of Developing Type 2 Diabetes in the General Population
  Sara Sokooti, Lyanne M. Kieneker, Martin H. de Borst, Anneke Muller Kobold, Jenny E. Kootstra-Ros, Jolein Gloerich, Alain J. van Gool, Hiddo J. Lambers Heerspink, Ron T Gansevoort, Robin P.F. Dullaart, Stephan J. L. Bakker
  Journal of Clinical Medicine.2020; 9(9): 3001.     CrossRef

• Effect of Anthocyanins Supplementation on Serum IGFBP-4 Fragments and Glycemic Control in Patients with Fasting Hyperglycemia: A Randomized Controlled Trial

  
  Liping Yang, Zhaomin Liu, Wenhua Ling, Li Wang, Changyi Wang, Jianping Ma, Xiaolin Peng, Jianying Chen
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 3395.     CrossRef
• Adipose Mitochondrial Respiratory Capacity in Obesity is Impaired Independently of Glycemic Status of Tissue Donors
  Britta Wessels, Julius Honecker, Theresa Schöttl, Lynne Stecher, Martin Klingenspor, Hans Hauner, Thomas Skurk
  Obesity.2019; 27(5): 756.     CrossRef
• Higher Plasma Level of Nampt Presaging Memory Dysfunction in Chinese Type 2 Diabetes Patients with Mild Cognitive Impairment
  Xi Huang, Chenchen Wang, Sai Tian, Rong Huang, Dan Guo, Haoqiang Zhang, Jijing Shi, Shaohua Wang
  Journal of Alzheimer's Disease.2019; 70(1): 303.     CrossRef
• Increased Ratio of Global O-GlcNAcylation to Tau Phosphorylation at Thr212 Site Is Associated With Better Memory Function in Patients With Type 2 Diabetes
  Rong Huang, Sai Tian, Jing Han, Rongrong Cai, Hongyan Lin, Dan Guo, Jiaqi Wang, Shaohua Wang
  Frontiers in Physiology.2019;[Epub]     CrossRef
• Pancreatic fat content is associated with β-cell function and insulin resistance in Chinese type 2 diabetes subjects
  Ting Lu, Yao Wang, Ting Dou, Bizhen Xue, Yuanyuan Tan, Jiao Yang
  Endocrine Journal.2019; 66(3): 265.     CrossRef
• Effectiveness of Eriomin® in managing hyperglycemia and reversal of prediabetes condition: A double‐blind, randomized, controlled study
  Carolina B. Ribeiro, Fernanda M. Ramos, John A. Manthey, Thais B. Cesar
  Phytotherapy Research.2019; 33(7): 1921.     CrossRef
• Association between plasma adipsin level and mild cognitive impairment in Chinese patients with type 2 diabetes: a cross-sectional study
  Dan Guo, Yang Yuan, Rong Huang, Sai Tian, Jiaqi Wang, Hongyan Lin, Ke An, Jin Han, Shaohua Wang
  BMC Endocrine Disorders.2019;[Epub]     CrossRef
• Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia
  Bernd Richter, Bianca Hemmingsen, Maria-Inti Metzendorf, Yemisi Takwoingi
  Cochrane Database of Systematic Reviews.2018;[Epub]     CrossRef
• OGTT 1h serum C-peptide to plasma glucose concentration ratio is more related to beta cell function and diabetes mellitus
  Hongmei Zhang, Bingxian Bian, Fan Hu, Qing Su
  Oncotarget.2017; 8(31): 51786.     CrossRef
• Articles inEndocrinology and Metabolismin 2016
  Won-Young Lee
  Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
• Obesity Influence on Insulin Activity and Resting Metabolic Rate in Type 2 Diabetes
  Rodica Doros, Daniela Lixandru, Laura Petcu, Ariana Picu, Manuela Mitu, Janeta Tudosoiu, Constantin Ionescu-Tîrgoviste
  Romanian Journal of Diabetes Nutrition and Metabolic Diseases.2016; 23(4): 377.     CrossRef
• Insulin Secretory Capacity and Insulin Resistance in Korean Type 2 Diabetes Mellitus Patients
  Jong-Dai Kim, Won-Young Lee
  Endocrinology and Metabolism.2016; 31(3): 354.     CrossRef
• Prediction of Diabetes Using Serum C-Peptide
  Hye Seung Jung
  Endocrinology and Metabolism.2016; 31(2): 275.     CrossRef

Citations

Citations to this article as recorded by  

• Homeostasis Model Assessment of β-Cell Function for Diagnosis of Insulinoma
  Kálmán Bódis, Martin Schön, Laura Dauben, Miriam Wilker, Klaus Strassburger, Volker Burkart, Michael Roden, Karsten Müssig
  The Journal of Clinical Endocrinology & Metabolism.2024; 109(3): e1125.     CrossRef
• A novel diagnostic model for insulinoma
  Feng Wang, Zhe Yang, XiuBing Chen, Yiling Peng, HaiXing Jiang, ShanYu Qin
  Discover Oncology.2022;[Epub]     CrossRef
• Comparison of the diagnostic accuracy of the current guidelines for detecting insulinoma
  Laura Dauben, Marie-Christine Simon, Klaus Strassburger, Volker Burkart, Katharina S Weber, Sven Schinner, Michael Roden, Karsten Müssig
  European Journal of Endocrinology.2019; 180(6): 381.     CrossRef
• EUS-guided lauromacrogol ablation of insulinomas: a novel treatment
  Shanyu Qin, Yongru Liu, Hongjian Ning, Lin Tao, Wei Luo, Donghong Lu, Zuojie Luo, Yingfen Qin, Jia Zhou, Junqiang Chen, Haixing Jiang
  Scandinavian Journal of Gastroenterology.2018; 53(5): 616.     CrossRef
• Diagnosis of insulinoma using the ratios of serum concentrations of insulin and C-peptide to glucose during a 5-hour oral glucose tolerance test
  Xu Li, Feng Zhang, Haibing Chen, Haoyong Yu, Jian Zhou, Ming Li, Qing Li, Lianxi Li, Jun Yin, Fang Liu, Yuqian Bao, Junfeng Han, Weiping Jia
  Endocrine Journal.2017; 64(1): 49.     CrossRef
• Insulinoma in a 5‐Year‐Old Dexter Cow
  C. Binici, S. Plog, O. Kershaw, M. Schmicke, J.H. van der Kolk, K.E. Müller
  Journal of Veterinary Internal Medicine.2016; 30(4): 1402.     CrossRef
• Vague neuroglycopenic complaints camouflage diagnosis of adolescent insulinoma: a case report
  Kelsee Halpin, Ryan McDonough, Patria Alba, Jared Halpin, Vivekanand Singh, Yun Yan
  International Journal of Pediatric Endocrinology.2016;[Epub]     CrossRef
• Articles in 'Endocrinology and Metabolism' in 2014
  Won-Young Lee
  Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef